We are live on
!
Find out more
GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
1-Year Est. Return
38.41%
This Fund
S&P 500
This Quarter
Est. Return
+14.23%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$344M
AUM Growth
+$70.5M
(+26%)
Cap. Flow
+$63.6M
Cap. Flow
% of AUM
18.5%
Top 10 Holdings %
Top 10 Hldgs %
73.13%
Holding
133
New
35
Increased
19
Reduced
40
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVRO
NEVRO CORP.
NVRO
|
+$5.61M |
| 2 |
HIMX
Himax Technologies
HIMX
|
+$2.67M |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$2.5M |
| 4 |
Protolabs
PRLB
|
+$1.98M |
| 5 |
INVN
Invensense Inc
INVN
|
+$1.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXON
Axon Enterprise
AXON
|
+$4.96M |
| 2 |
OVTI
OMNIVISION TECHNOLOGIES INC
OVTI
|
+$4.17M |
| 3 |
ISSI
INTEGRATED SILICON SOLUTN INC
ISSI
|
+$3.91M |
| 4 |
Gentex
GNTX
|
+$3.2M |
| 5 |
Palo Alto Networks
PANW
|
+$2.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.18% |
| 2 | Consumer Discretionary | 4.62% |
| 3 | Technology | 3.83% |
| 4 | Consumer Staples | 1.87% |
| 5 | Industrials | 1.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
iShares Russell 2000 ETF
IWM
$79.1B
| $190M | 55.14% |
1,525,000
+625,000
| +69% | +$78.1M |
|
2
CALL
iShares China Large-Cap ETF
FXI
$4.32B
| $15.4M | 4.47% |
+333,000
| New | +$16.5M |
|
|
NVRO
3
DELISTED
NEVRO CORP.
NVRO
| $8.95M | 2.6% |
166,450
+110,050
| +195% | +$5.61M |
|
|
ADPT
4
DELISTED
Adeptus Health Inc
ADPT
| $8.46M | 2.46% |
89,098
+19,098
| +27% | +$1.31M |
|
|
OVTI
5
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $7.51M | 2.18% |
286,568
-155,632
| -35% | -$4.17M |
|
|
ARIA
6
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $5.83M | 1.7% |
705,580
-194,420
| -22% | -$1.72M |
|
|
WX
7
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $5.39M | 1.57% |
127,464
-52,536
| -29% | -$2.22M |
|
|
TTPH
8
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $3.57M | 1.04% |
3,760
-203
| -5% | -$166K |
|
|
CSII
9
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.38M | 0.98% |
127,960
+77,260
| +152% | +$2.5M |
|
|
CBPO
10
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $3.36M | 0.98% |
29,160
-10,840
| -27% | -$1.14M |
|
11
PUT
iShares MSCI Emerging Markets ETF
EEM
$27.5B
| $3.17M | 0.92% |
+80,000
| New | +$3.35M |
|
|
HIMX
12
Himax Technologies
HIMX
$2.03B
| $3.16M | 0.92% |
+393,280
| New | +$2.67M |
|
13
Motorcar Parts of America
MPAA
$266M
| $3.01M | 0.88% |
100,000
+60,000
| +150% | +$1.75M |
|
|
XENT
14
DELISTED
Intersect ENT, Inc
XENT
| $2.84M | 0.83% |
99,204
+19,204
| +24% | +$503K |
|
15
Meta Platforms (Facebook)
META
$1.49T
| $2.71M | 0.79% |
31,592
-13,408
| -30% | -$1.09M |
|
16
Good Times Restaurants
GTIM
$14.9M
| $2.56M | 0.75% |
291,174
+141,174
| +94% | +$1.23M |
|
17
JD.com
JD
$43.5B
| $2.01M | 0.59% |
59,048
+1,048
| +2% | +$35.6K |
|
|
SPNC
18
DELISTED
Spectranetics Corp
SPNC
| $2M | 0.58% |
87,138
+51,138
| +142% | +$1.43M |
|
|
INVN
19
DELISTED
Invensense Inc
INVN
| $1.96M | 0.57% |
+129,600
| New | +$1.96M |
|
|
BEAT
20
DELISTED
BioTelemetry, Inc.
BEAT
| $1.9M | 0.55% |
201,832
-48,168
| -19% | -$446K |
|
|
DOC
21
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.89M | 0.55% |
123,120
-66,880
| -35% | -$1.11M |
|
|
22
Protolabs
PRLB
$1.7B
| $1.89M | 0.55% |
+28,000
| New | +$1.98M |
|
|
XUE
23
DELISTED
XUEDA EDUCATION GROUP ADS REPTG 2 ORD SHS
XUE
| $1.87M | 0.54% |
493,928
+309,028
| +167% | +$1.07M |
|
24
General Motors
GM
$80.9B
| $1.87M | 0.54% |
56,000
-34,000
| -38% | -$1.21M |
|
25
Vipshop
VIPS
$7.26B
| $1.82M | 0.53% |
81,768
-34,232
| -30% | -$907K |
|
Similar funds
MAM
CCM
BGCI
CAM
EAM
SM
TPL
RC
Granite Point Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Granite Point Capital Management held 133 positions worth $344M, up 26% from $273M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Granite Point Capital Management deployed $63.6M of net new capital in Q2 2015, opening 35 new positions and adding to 19 existing holdings. Its largest new stake was Himax Technologies: 393,280 shares worth $3.16M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Axon Enterprise, an estimated $4.96M trimmed.
- Granite Point Capital Management's largest Q2 2015 buy was Himax Technologies: 393,280 shares worth $3.16M.
- Granite Point Capital Management added most to NEVRO CORP. in Q2 2015, an estimated $5.61M increase.
- Granite Point Capital Management's biggest Q2 2015 reduction was Axon Enterprise, cutting an estimated $4.96M.
- Granite Point Capital Management fully exited INTEGRATED SILICON SOLUTN INC in Q2 2015, selling an estimated $3.91M.
- Granite Point Capital Management's ten largest holdings make up 73% of its $344M portfolio in Q2 2015.
- Granite Point Capital Management opened 35 new positions and closed 35 in Q2 2015.
- Granite Point Capital Management's portfolio value rose 26% quarter-over-quarter to $344M.
Based on Granite Point Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.